Lynne Sullivan - CFO & Head of Corp. Dev. at Unity Biotechnology, Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
CFO & Head of Corp. Dev.
Stock Symbol
UBX on Nasdaq
Industry
Pharmaceutical Preparations
All Insider Reports
All Insider Reports

Lynne Sullivan - trading volume in the past year for Unity Biotechnology, Inc.

Holdings reported by Lynne Sullivan for Unity Biotechnology, Inc.

Security Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Stock, $0.0001 par value 98.9K $102K $1.03 Apr 2, 2025 Direct
Stock Option (Right to Buy) 106K Mar 28, 2025 Direct Common Stock

Transactions reported by Lynne Sullivan for Unity Biotechnology, Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.